Pharmacokinetics of the protease inhibitor KNI-272 in plasma and cerebrospinal fluid in nonhuman primates after intravenous dosing and in human immunodeficiency virus-infected children after intravenous and oral dosing
about
Pharmacokinetics of the protease inhibitor KNI-272 in plasma and cerebrospinal fluid in nonhuman primates after intravenous dosing and in human immunodeficiency virus-infected children after intravenous and oral dosing
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Pharmacokinetics of the protea ...... er intravenous and oral dosing
@ast
Pharmacokinetics of the protea ...... er intravenous and oral dosing
@en
type
label
Pharmacokinetics of the protea ...... er intravenous and oral dosing
@ast
Pharmacokinetics of the protea ...... er intravenous and oral dosing
@en
prefLabel
Pharmacokinetics of the protea ...... er intravenous and oral dosing
@ast
Pharmacokinetics of the protea ...... er intravenous and oral dosing
@en
P2093
P2860
P1476
Pharmacokinetics of the protea ...... er intravenous and oral dosing
@en
P2093
B D Anderson
B U Mueller
C L McCully
J Zuckerman
M Q Farley
P Jarosinski
P2860
P304
P407
P577
1998-07-01T00:00:00Z